Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance
about
The HIV glycan shield as a target for broadly neutralizing antibodiesComposition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope GlycoproteinHIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesOptimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodiesStructure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodiesMolecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.Antibody recognition of HIV and dengue glycoproteins.Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.Dense Array of Spikes on HIV-1 Virion Particles.Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimerGlycosylation profiling to evaluate glycoprotein immunogens against HIV-1.Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.Exploiting glycan topography for computational design of Env glycoprotein antigenicity.Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.Structural Rearrangements Maintain the Glycan Shield of an HIV-1 Envelope Trimer After the Loss of a Glycan
P2860
Q26786540-AF7432FC-9CA2-462F-B0F6-CB58014366CBQ29306052-F7AFF15E-FE7D-4DAD-999F-4DE2256CFDC1Q30393763-3665DAA9-796C-4BA5-863C-383CA4B671A2Q35743897-03B246E0-6DC6-47EC-A3AA-E2065C577CA6Q35974269-1DA9E317-98D4-4D33-BBE2-A1B9FFD219D3Q36105672-443FCE7A-9079-472B-9451-5CFC0A91D885Q36246403-80AA380E-04C6-425D-AC83-06CFD953A231Q36531018-8521C252-2FAC-4427-9E8C-DB6C0E3531E3Q38290294-3AE201AA-A167-46A7-B6AB-BD3003352DC3Q38293417-16EEE405-09C7-4564-9E1A-D85968D12906Q38645979-20453055-ECF1-423A-BA05-C532F5F72286Q38817990-31DF4175-810C-4805-BEEB-210D827C01B6Q39949085-39BD2B28-1CEE-485F-9DF8-A69FD922A2F1Q40058876-243F14DA-6156-4FEA-80B2-00C83ECE3090Q40276435-F9B5E27E-F219-46AE-AD80-B69122FB1E64Q52314288-8AA401DF-5005-4B3C-95A3-42650BEF64A6Q52673965-7D9D6499-C1E8-4A16-9789-05A7A0C01B0AQ57292375-773BF235-B603-4CF8-97F0-F002370F0C54
P2860
Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@en
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@nl
type
label
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@en
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@nl
prefLabel
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@en
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@nl
P2093
P2860
P356
P1433
P1476
Glycan Microheterogeneity at t ...... for Neutralization Resistance
@en
P2093
Daniel I R Spencer
Laura K Pritchard
Louise Royle
Snezana Vasiljevic
Stefanie A Krumm
P2860
P304
P356
10.1128/JVI.00230-15
P407
P577
2015-04-15T00:00:00Z